Bristol-Myers Squibb (BMY) EPS & PE Ratio History
Current and historical earning per share (EPS) and price to earnings (PE) ratio for Bristol-Myers Squibb (BMY) over the last 10 years. The current PE ratio for Bristol-Myers Squibb as of August 16, 2017 is 19.30.
|Medical||Large Cap Pharmaceutical||$94.296B||$19.427B|
|Bristol-Myers Squibb Company is a global leader in the research and development of innovative lifesaving and life-enhancing treatments for heart disease; high blood pressure; stroke; diabetes; cancer; HIV/AIDS and other infectious diseases; depression, schizophrenia and other mental disorders; pain; and other conditions.|